A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide

Mise à jour : Il y a 4 ans
Référence : NCT00234520

Femme et Homme

Extrait

The aim of the study is to compare the risk of acromegaly patients developing valvular regurgitation when receiving lanreotide or octreotide


Critère d'inclusion

  • Acromegaly


Liens